ArticleCase reports in gastroenterology
Duodenal Perforation following Argon Plasma Coagulation for Angiodysplasia: A Case Report.
Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Argon plasma coagulation (APC) is a widely used technique for hemostasis and ablation in gastrointestinal tract lesions due to its ease of use and safety. However, gastrointestinal tract muscle injury can occur with high-power settings and prolonged application. Case Presentation: We present a case of an elderly female with angiodysplasia bleeding in the second portion of the duodenum treated with APC, resulting in a complication of bowel wall perforation and peritonitis. Conclusion: Acute perforation has been rarely reported with APC, either due to direct wall injury or explosion from overinflation. To avoid perforation, careful control of ablation power and duration, especially in regions with a thin gastrointestinal wall such as the gastric fundus and ascending colon, should be maintained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.